RHUMBLINE ADVISERS - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 238 filers reported holding BLUEBIRD BIO INC in Q1 2021. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$505,715
-7.3%
166,358
+0.3%
0.00%0.0%
Q2 2023$545,580
+104417.2%
165,830
+1.0%
0.00%0.0%
Q1 2023$522
-41.7%
164,250
+26.9%
0.00%0.0%
Q4 2022$896
-99.9%
129,431
+6.2%
0.00%0.0%
Q3 2022$771,000
+75.2%
121,870
+14.7%
0.00%0.0%
Q2 2022$440,000
+0.9%
106,287
+18.3%
0.00%0.0%
Q1 2022$436,000
-55.2%
89,848
-7.8%
0.00%0.0%
Q4 2021$974,000
-48.2%
97,489
-1.0%
0.00%
-66.7%
Q3 2021$1,882,000
-39.7%
98,506
+0.9%
0.00%
-25.0%
Q2 2021$3,123,000
+44.2%
97,648
+36.0%
0.00%
+33.3%
Q1 2021$2,165,000
-33.2%
71,810
-4.1%
0.00%
-25.0%
Q4 2020$3,239,000
-23.9%
74,855
-5.1%
0.00%
-42.9%
Q3 2020$4,255,000
-9.4%
78,870
+2.5%
0.01%
-12.5%
Q2 2020$4,696,000
+65.2%
76,933
+24.4%
0.01%
+33.3%
Q1 2020$2,842,000
-33.3%
61,835
+27.4%
0.01%
-14.3%
Q4 2019$4,258,000
-1.7%
48,523
+2.8%
0.01%
-12.5%
Q3 2019$4,333,000
-27.2%
47,194
+0.9%
0.01%
-27.3%
Q2 2019$5,952,000
-30.3%
46,795
-13.8%
0.01%
-35.3%
Q1 2019$8,545,000
+54.7%
54,313
-2.5%
0.02%
+41.7%
Q4 2018$5,525,000
-32.9%
55,691
-1.3%
0.01%
-25.0%
Q3 2018$8,237,000
-2.1%
56,415
+5.2%
0.02%
-5.9%
Q2 2018$8,414,000
-5.0%
53,609
+3.3%
0.02%
-10.5%
Q1 2018$8,859,000
-7.0%
51,882
-3.0%
0.02%0.0%
Q4 2017$9,524,000
+13.4%
53,473
-12.6%
0.02%
+5.6%
Q3 2017$8,399,000
+50.6%
61,149
+15.2%
0.02%
+38.5%
Q2 2017$5,576,000
+14.1%
53,082
-1.3%
0.01%
+18.2%
Q1 2017$4,889,000
+61.5%
53,780
+9.6%
0.01%
+37.5%
Q4 2016$3,027,000
-5.8%
49,058
+3.5%
0.01%
-11.1%
Q3 2016$3,214,000
+63.6%
47,412
+4.4%
0.01%
+50.0%
Q2 2016$1,965,000
+30.7%
45,401
+28.4%
0.01%
+20.0%
Q1 2016$1,503,000
-34.7%
35,365
-1.4%
0.01%
-28.6%
Q4 2015$2,303,000
-20.4%
35,855
+6.0%
0.01%
-30.0%
Q3 2015$2,894,000
-46.1%
33,832
+6.1%
0.01%
-41.2%
Q2 2015$5,368,000
+70.5%
31,882
+22.3%
0.02%
+88.9%
Q1 2015$3,149,000
+87.3%
26,075
+42.3%
0.01%
+80.0%
Q4 2014$1,681,000
+177.9%
18,330
+8.6%
0.01%
+150.0%
Q3 2014$605,000
-2.4%
16,875
+4.9%
0.00%0.0%
Q2 2014$620,00016,0800.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q1 2021
NameSharesValueWeighting ↓
Monashee Investment Management LLC 125,000$13,131,0005.55%
Cormorant Asset Management, LP 275,000$28,889,0004.79%
Eventide Asset Management 569,700$59,847,0003.73%
Crosspoint Capital Strategies, LLC 28,937$3,040,0002.66%
Casdin Capital, LLC 65,000$6,828,0002.53%
ARK Investment Management 119,683$12,573,0002.45%
RTW INVESTMENTS, LP 104,383$10,965,0002.31%
Taylor Wealth Management Partners 38,368$4,031,0001.82%
First Light Asset Management, LLC 33,780$3,549,0001.19%
Atika Capital Management LLC 25,000$2,627,0000.92%
View complete list of BLUEBIRD BIO INC shareholders